Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aducanumab Approval Decision Delayed: Could This Be Good News?
Amendment Triggered Three-Month Review Extension
Jan 29 2021
•
By
Mandy Jackson
The FDA requested more information on aducanumab and then delayed its approval decision until 7 June • Source: Shutterstock
More from New Products
More from Scrip